What Sec of State Tillerson's Ouster Means for US DiplomacyTop of Mind with Julie Rose • Season 1, Episode 767, Segment 1
Mar 13, 2018 • 24m
Guest: Eric Jensen, JD, Professor of Law, BYU US Foreign Policy is Top of Mind today. President Trump announced on Twitter this morning that Rex Tillerson is out as Secretary of State and he’ll nominate CIA director Mike Pompeo to the position. Just before boarding a helicopter on the White House lawn this morning, President Trump explained his reasons for going with Pompeo: “I’ve worked with Mike Pompeo now for quite some time – tremendous energy, tremendous intellect – we’re always on the same wavelength. The relationship has been very good and that’s what I need as Secretary of State. I wish Rex Tillerson well.” What are the implications of this change?

23andMe Breast Cancer Genetics Testing
23andMe Breast Cancer Genetics TestingMar 13, 201811mGuest: Laura Hercher, MS, Director of Student Research, Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College If you send in a sample of your saliva to 23andMe, the genetics-testing company will send you a report about where your ancestors came from, and you can pay extra to find out if you’re at risk for Parkinson’s or Late-Onset Alzheimer’s. Just last week, the Federal Drug Administration also gave 23andMe the green light to screen for three mutations that increase the risk of breast and ovarian cancer. It was screening positive for mutations on these BRCA genes that led Angelina Jolie to have a double mastectomy. This is the first time the FDA has authorized this screening by a company selling directly to consumers.
Guest: Laura Hercher, MS, Director of Student Research, Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College If you send in a sample of your saliva to 23andMe, the genetics-testing company will send you a report about where your ancestors came from, and you can pay extra to find out if you’re at risk for Parkinson’s or Late-Onset Alzheimer’s. Just last week, the Federal Drug Administration also gave 23andMe the green light to screen for three mutations that increase the risk of breast and ovarian cancer. It was screening positive for mutations on these BRCA genes that led Angelina Jolie to have a double mastectomy. This is the first time the FDA has authorized this screening by a company selling directly to consumers.